Cerus Corp (CERS) - Medical Equipment - Deals and Alliances Profile

Region:North America

Author(s):

Product Code:GDME26394D

Download Sample Report download
Buy the Full ReportStarting from $250
Published on

October 2018

Total pages

41

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $250

About the Report

About the Report

Summary

Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide range of pathogens including viruses, bacteria and parasites present in donated blood. The product is for use with three blood components, platelets, plasma and red blood cells. Cerus is marketed and sold in several countries worldwide including the US, Belgium, Kuwait, France, Spain, Portugal, Switzerland, CIS countries and other countries. Cerus is headquartered in Concord, California, the US.

Cerus Corp (CERS)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Products

Products

Cerus Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Table of Contents

Table of Contents

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cerus Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cerus Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Cerus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cerus Corp, Medical Equipment, Deal Details 10

Partnerships 10

Cerus Enters into Agreement with Kedrion Biopharma 10

Cerus Enters into Agreement with Haemonetics 11

Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 12

Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 13

Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 14

Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 15

Equity Offering 16

Cerus Raises USD57.5 Million in Public Offering of Shares 16

Cerus Plans to Raise USD70 Million in Public Offering of Shares 17

Cerus Prices Public Offering of Shares for USD70 Million 18

Cerus Completes Public Offering Of Shares For USD 40.3 Million 19

Cerus Corp-Key Competitors 21

Cerus Corp-Key Employees 22

Cerus Corp-Locations And Subsidiaries 23

Head Office 23

Other Locations & Subsidiaries 23

Recent Developments 24

Financial Announcements 24

Aug 02, 2018: Cerus announces second quarter 2018 financial results 24

May 08, 2018: Cerus Reports First Quarter 2018 Results 26

Mar 08, 2018: Cerus Reports Fourth Quarter And Year End 2017 Financial Results 28

Jan 08, 2018: Cerus Announces Preliminary Product Revenue Results for Fourth Quarter and Full Year 2017 30

Nov 02, 2017: Cerus Corporation Reports Third Quarter 2017 Results 31

Aug 03, 2017: Cerus Reports Second Quarter 2017 Results 33

May 03, 2017: Cerus Reports First Quarter 2017 Results 35

Mar 07, 2017: Cerus Reports Fourth Quarter and Year End 2016 Results 36

Corporate Communications 38

Oct 09, 2018: Cerus appoints Eric Bjerkholt to board of directors 38

Other Significant Developments 39

Oct 31, 2017: Cerus and Kedrion Biopharma Enter Distribution Agreement for the Full INTERCEPT Blood System Portfolio in Italy 39

Jun 07, 2017: Cerus Provides Update on U.S. Platelet Additive Solution Supply 40

Appendix 41

Methodology 41

About GlobalData 41

Contact Us 41

Disclaimer 41


List of Figure

List of Figures

Cerus Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Cerus Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cerus Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cerus Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List of Table

List of Tables

Cerus Corp, Medical Equipment, Key Facts, 2017 2

Cerus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Cerus Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Cerus Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Cerus Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Cerus Corp, Deals By Market, 2012 to YTD 2018 8

Cerus Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Cerus Enters into Agreement with Kedrion Biopharma 10

Cerus Enters into Agreement with Haemonetics 11

Cerus Enters into Agreement with Kawasumi Labs to Develop Intercept Platelets Kits in Japan 12

Cerus Enters into Co-Marketing Agreement with Biomedica Foscama 13

Cerus Enters Into Distribution Agreement With American Red Cross For Intercept Plasma 14

Cerus Enters Into Distribution Agreement With Blood Systems For Intercept Plasma 15

Cerus Raises USD57.5 Million in Public Offering of Shares 16

Cerus Plans to Raise USD70 Million in Public Offering of Shares 17

Cerus Prices Public Offering of Shares for USD70 Million 18

Cerus Completes Public Offering Of Shares For USD 40.3 Million 19

Cerus Corp, Key Competitors 21

Cerus Corp, Key Employees 22

Cerus Corp, Subsidiaries 23

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022